Jan 02, 2024

Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study

Read more

Dec 24, 2023

Light-Chain Amyloidosis: The Great Impostor

Read more

Dec 14, 2023

Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment

Read more

Nov 30, 2023

Recent Progress in the Development and Clinical Application of New Drugs for Transthyretin Cardiac Amyloidosis

Read more

Nov 23, 2023

AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management

Read more

Nov 23, 2023

Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy

Read more

Oct 24, 2023

PLAIN LANGUAGE SUMMARY: From older to younger: intergenerational promotion of health behaviours in Portuguese families affected by familial amyloid polyneuropathy

Read more

Oct 12, 2023

Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal

Read more

Oct 05, 2023

Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy

Read more

Jan 29, 2023

Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: a plain language summary

Read more

Subscribe to